Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Polio Still a Threat to Public Health

Live virus used in polio vaccine can evolve and infect, warns TAU researcher

Health professionals and researchers across the globe believe they are on the verge of eradicating polio, a devastating virus which can lead to paralysis and death. Despite successful eradication in most countries, there are still four countries where the virus is considered endemic — and many more in which the virus still lurks.

Dr. Lester Shulman of Tel Aviv University's Sackler Faculty of Medicine and the Israeli Ministry of Health has spent years tracking isolated cases of live poliovirus infections, often discovered in countries that are supposedly polio-free. When the live-virus version of the vaccine, called Oral Polio Vaccine (OPV) evolves, he says, it can act like wild poliovirus and continue the threat of contagion.

Medical professionals widely believe that after the wild virus is eradicated, resources dedicated to polio immunization can be redirected. But this isn't so, he says. He recommends that public health agencies take a three-pronged approach: Vaccination policies to maintain "herd immunity" (a 95 percent immunization rate for polio) should be maintained to prevent the spread of wild and evolved vaccine strains of the virus; environmental surveillance of sewage systems should continue; and a switch to Inactivated Polio Vaccine (IPV) instead of OPV should be implemented.

Dr. Shulman's research was recently published in PLoS ONE. He has also been invited as an informal expert to the World Health Organization's annual meeting on polio this fall.

A decade-long chase

While the eradication of polio is seemingly within reach, this is not the time to relax, Dr. Shulman warns. Most countries only investigate the possibility of poliovirus outbreaks when paralytic cases appear in the human population. But this doesn't take into account a potential problem posed by the live virus vaccine. Over time, the vaccine can mutate, and even a 1 percent genomic change in the virus permits the virus to behave like a wild poliovirus. If a population isn't sufficiently immunized, this spells trouble.

Israel is among the few countries that practice environmental surveillance for polio, beginning in 1989. Checking designated sites along sewage systems every month for evidence of the virus allows for early detection before there are paralytic cases. For the past decade, the researchers have been trying to trace the origin of the strain that infected two individuals in Central Israel. They tracked the strains to the sewage system, and have been working to pinpoint the origin. Fortunately, because Israel maintains herd immunity for the disease, the wider population has not been threatened.

Dr. Shulman says that in the lab, each strain of the virus can be identified from its genomic structure and traced back to the region from which it originated. "From the sequence of the genome, you can match it with known sequences reported by labs throughout the world," he explains. For example, he and his colleagues traced a wild poliovirus discovered in sewage from the Gaza District to a village in Egypt.

New hope for curing persistent infections

Convinced by the efficacy of Israel's environmental surveillance program, many other countries are starting to develop tracking programs of their own. As a result, they are finding evidence of vaccine-derived polio cases in humans. Paradoxically, Dr. Shulman sees a beacon of hope in these discoveries. As labs across the world report more cases, researchers gain a better understanding of how polioviruses establish persistent infections and can then develop effective measures to eliminate them.

The fellow researchers are now working to develop compounds that can effectively fight these rare cases of persistent poliovirus infections. So far, they have seen promising results, noting that the mutants strains have not become resistant to the drugs under investigation. But for now, Dr. Shulman recommends that health authorities continue immunization using inactivated vaccines (IPV) to keep their populations safe.

George Hunka | EurekAlert!
Further information:

Further reports about: IPV Vaccine health services persistent infections virus infection

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

TRAPPIST-1 planets provide clues to the nature of habitable worlds

21.03.2018 | Physics and Astronomy

The search for dark matter widens

21.03.2018 | Materials Sciences

Natural enemies reduce pesticide use

21.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>